Children with suspected or confirmed pulmonary TB or tuberculous peripheral
lymphadenitis who live in settings with low HIV prevalence or low prevalence
of isoniazid resistance1 and children who are HIV-negative can be treated with
a three-drug regimen (HRZ) for 2 months followed by a two-drug (HR) regimen
for 4 months at the dosages specified in Recommendation 8